BioCentury
ARTICLE | Clinical News

Myozyme alglucosidase alfa regulatory update

March 2, 2009 8:00 AM UTC

The EC approved an MAA from Genzyme for Myozyme alglucosidase produced in a 4,000 liter-bioreactor to treat Pompe's disease. Genzyme said the product would be launched immediately. In January, Genzyme...